Annual Report 2024

Annual Report 2024

Consolidated Statements of Changes in Equity

Consolidated Statements of Changes in Equity

(in thousands of $)
Attributable to owners of the parent

 

Share capital

 

Share premium

 

Accumulated losses

 

Translation differences

 

Share-based payment and income tax deduction on share-based payments

 

Fair value movement on investment in equity instruments designated as at FVTOCI

 

Total equity attributable to owners of the parent

 

Total equity

Balance on January 1, 2022

 

6,233

 

3,462,775

 

(1,400,197)

 

131,684

 

373,019

 

(39,290)

 

2,534,224

 

2,534,224

Loss for the year

 

 

 

 

 

(709,594)

 

 

 

 

 

 

 

(709,594)

 

(709,594)

Other comprehensive income/(loss)

 

 

 

 

 

 

 

(2,404)

 

 

 

(18,267)

 

(20,671)

 

(20,671)

Total comprehensive income/(loss) for the year

 

 

 

(709,594)

 

(2,404)

 

 

(18,267)

 

(730,266)

 

(730,266)

Income tax benefit from excess tax deductions related to share-based payments

 

 

 

 

 

 

 

 

 

3,946

 

 

 

3,946

 

3,946

Share-based payment

 

 

 

 

 

 

 

 

 

158,282

 

 

 

158,282

 

158,282

Issue of share capital

 

294

 

760,659

 

 

 

 

 

 

 

 

 

760,953

 

760,953

Transaction costs for equity issue

 

 

 

(781)

 

 

 

 

 

 

 

 

 

(781)

 

(781)

Exercise of stock options

 

113

 

93,082

 

 

 

 

 

 

 

 

 

93,195

 

93,195

Ordinary shares withheld for payment of employees’ withholding tax liability

 

 

 

(5,855)

 

 

 

 

 

 

 

 

 

(5,855)

 

(5,855)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance on December 31, 2022

 

6,640

 

4,309,880

 

(2,109,791)

 

129,280

 

535,247

 

(57,557)

 

2,813,699

 

2,813,699

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss for the year

 

 

 

 

 

(295,053)

 

 

 

 

 

 

 

(295,053)

 

(295,053)

Other comprehensive income/(loss)

 

 

 

 

 

 

 

2,263

 

 

 

(1,915)

 

348

 

348

Total comprehensive income/(loss) for the year

 

 

 

(295,053)

 

2,263

 

 

(1,915)

 

(294,705)

 

(294,705)

Income tax benefit from excess tax deductions related to share-based payments

 

 

 

 

 

 

 

 

 

2,310

 

 

 

2,310

 

2,310

Share-based payment

 

 

 

 

 

 

 

 

 

234,168

 

 

 

234,168

 

234,168

Issue of share capital

 

288

 

1,196,444

 

 

 

 

 

 

 

 

 

1,196,732

 

1,196,732

Transaction costs for equity issue

 

 

 

(821)

 

 

 

 

 

 

 

 

 

(821)

 

(821)

Exercise of stock options

 

130

 

158,133

 

 

 

 

 

 

 

 

 

158,263

 

158,263

Ordinary shares withheld for payment of employees’ withholding tax liability

 

 

 

(12,139)

 

 

 

 

 

 

 

 

 

(12,139)

 

(12,139)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance on December 31, 2023

 

7,058

 

5,651,497

 

(2,404,844)

 

131,543

 

771,725

 

(59,472)

 

4,097,507

 

4,097,507

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the year

 

 

 

 

 

833,040

 

 

 

 

 

 

 

833,040

 

833,040

Other comprehensive income/(loss)

 

 

 

 

 

 

 

(4,711)

 

 

 

(648)

 

(5,359)

 

(5,359)

Total comprehensive income/(loss) for the year

 

 

 

833,040

 

(4,711)

 

 

(648)

 

827,681

 

827,681

Income tax benefit from excess tax deductions related to share-based payments

 

 

 

 

 

 

 

 

 

39,650

 

 

 

39,650

 

39,650

Share-based payment

 

 

 

 

 

 

 

 

 

235,856

 

 

 

235,856

 

235,856

Exercise of stock options

 

169

 

319,288

 

 

 

 

 

 

 

 

 

319,457

 

319,457

Ordinary shares withheld for payment of employees’ withholding tax liability

 

 

 

(21,869)

 

 

 

 

 

 

 

 

 

(21,869)

 

(21,869)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance on December 31, 2024

 

7,227

 

5,948,916

 

(1,571,804)

 

126,832

 

1,047,231

 

(60,119)

 

5,498,283

 

5,498,283

Please refer to “Note 12 Share Capital and Share Premium” for more information on the share capital and movement in number of shares. See also “Note 13 Share-Based Payments” for more information on the share-based payments.

The accompanying notes form an integral part of these consolidated financial statements.